Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy

por Jin, Hyung-seung, Park, Yoon
Publicado 2021

Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy

por Lee, Dong-Hee, Choi, Seunghyun, Park, Yoon, Jin, Hyung-seung
Publicado 2021

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity

por Yeo, Jinah, Ko, Minkyung, Lee, Dong-Hee, Park, Yoon, Jin, Hyung-seung
Publicado 2021

PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers

por Lee, Dong-Hee, Jeong, Yu-Jeong, Won, Ju-Young, Sim, Hye-In, Park, Yoon, Jin, Hyung-Seung
Publicado 2022

Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors

por Kim, Nayoung, Lee, Dong-Hee, Choi, Woo Seon, Yi, Eunbi, Kim, HyoJeong, Kim, Jung Min, Jin, Hyung-Seung, Kim, Hun Sik
Publicado 2021

A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity

por Lee, Dong-hee, Ahn, Hyejin, Sim, Hye-In, Choi, Eunji, Choi, Seunghyun, Jo, Yunju, Yun, Bohwan, Song, Hyun Kyu, Oh, Soo Jin, Denda-Nagai, Kaori, Park, Chan-Sik, Irimura, Tatsuro, Park, Yoon, Jin, Hyung-seung
Publicado 2023

Enhancing adoptive T‐cell therapy with fucoidan‐based IL‐2 delivery microcapsules

por Jeon, Eun Young, Choi, Da‐som, Choi, Seunghyun, Won, Ju‐young, Jo, Yunju, Kim, Hye‐bin, Jung, Youngmee, Shin, Sang Chul, Min, Hophil, Choi, Hae Woong, Lee, Myeong Sup, Park, Yoon, Chung, Justin J., Jin, Hyung‐seung
Publicado 2022

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis

por Yoo, Changhoon, Lee, Sang Soo, Song, Ki Byung, Jeong, Jae Ho, Hyung, Jaewon, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Lee, Seung Soo, Kim, Jin Hee, Jin, Hyung-seung, Park, Jin-hong, Hwang, Dae Wook, Lee, Jae Hoon, Lee, Woohyung, Chang, Heung-Moon, Kim, Kyu-pyo, Ryoo, Baek-Yeol, Kim, Song Cheol
Publicado 2020

LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

por Sung, Eunsil, Ko, Minkyung, Won, Ju-young, Jo, Yunju, Park, Eunyoung, Kim, Hyunjoo, Choi, Eunji, Jung, Ui-jung, Jeon, Jaehyoung, Kim, Youngkwang, Ahn, Hyejin, Choi, Da-som, Choi, Seunghyun, Hong, Youngeun, Park, Hyeyoung, Lee, Hanbyul, Son, Yong-Gyu, Park, Kyeongsu, Won, Jonghwa, Oh, Soo Jin, Lee, Seonmin, Kim, Kyu-pyo, Yoo, Changhoon, Song, Hyun Kyu, Jin, Hyung-seung, Jung, Jaeho, Park, Yoon
Publicado 2022